Praj Industries - BIG Picture

155-175 Major support and also retest of breakout.
275-220 Probabable targets in medium term.

#PRAJIND https://t.co/dsbj25WPbQ

More from Shivaji Vitthalrao🇮🇳

BEML

1. Stock is consolidating in the band 100-120 on lower side & 1900-1950 on upper side.

2. CMP 1344 1st targets 1850-1950

3. Medium term targets 2400-2500

4. Long term taregts 3500 first and then 8,000-10,000 in next 4-5 yrs

5. This is going to be 15-16 years breakout https://t.co/BXMv5GjsGW


6. Stock hits high 160-175 in 1995 & 1997

7. went into down trend, consolidated for 3 yrs 1999-2002

8. Gave breakout above 34 hinting at major shift in Feb 2002

9. Gave 1st multi year breakout in Oct 2003 above 160-175 which was failed

10. Next attempt in Sep 2004 crossed 175


11. Above 1995-1997 highs (160-175) stock went on to become 10x in a matter of 20-22 months

12. CMP 1344 Multi year breakout will trigger above 1950 on weekly closing basis

13. Will be watching 1st breakout above 1950

14. SL 1260/1100 depends on risk of the trader or investor

More from Praj

You May Also Like

@EricTopol @NBA @StephenKissler @yhgrad B.1.1.7 reveals clearly that SARS-CoV-2 is reverting to its original pre-outbreak condition, i.e. adapted to transgenic hACE2 mice (either Baric's BALB/c ones or others used at WIV labs during chimeric bat coronavirus experiments aimed at developing a pan betacoronavirus vaccine)

@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice


@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2


@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj


@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o
1/“What would need to be true for you to….X”

Why is this the most powerful question you can ask when attempting to reach an agreement with another human being or organization?

A thread, co-written by @deanmbrody:


2/ First, “X” could be lots of things. Examples: What would need to be true for you to

- “Feel it's in our best interest for me to be CMO"
- “Feel that we’re in a good place as a company”
- “Feel that we’re on the same page”
- “Feel that we both got what we wanted from this deal

3/ Normally, we aren’t that direct. Example from startup/VC land:

Founders leave VC meetings thinking that every VC will invest, but they rarely do.

Worse over, the founders don’t know what they need to do in order to be fundable.

4/ So why should you ask the magic Q?

To get clarity.

You want to know where you stand, and what it takes to get what you want in a way that also gets them what they want.

It also holds them (mentally) accountable once the thing they need becomes true.

5/ Staying in the context of soliciting investors, the question is “what would need to be true for you to want to invest (or partner with us on this journey, etc)?”

Multiple responses to this question are likely to deliver a positive result.